New research indicates that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who stop conventional lifestyle programs.
Published data in a major health publication points out that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"People buying these drugs need to be aware of the risk of fast weight regain when the treatment ends," warns researcher Dr. Susan Jebb.
Such speed of recovery means a reversion to original weight within about one and a half years.
Analyzing Treatments
The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with conventional dieting.
Researchers note that people who shed pounds through dieting usually have a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Regain
Nutrition scientists propose the mechanism of the injections accounts for the amplified weight return.
These medications copy a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, given the high risk of relapse, the treatment is often long-term.
This opinion is reinforced by drug manufacturers, who state that the findings "emphasize the long-term character of excess weight," comparing it to managing conditions like high blood pressure.
User Experiences
Individuals who have discontinued the medication explain a intense resurgence of cravings.
"It was like a switch flipping and I was suddenly extremely hungry," said a patient.
This challenge is compounded if patients have not established sustainable dietary or behavioural changes during treatment.
Significant Adoption
Figures indicate that millions of people in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is more common among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
Ultimately, researchers emphasize that while the jabs are potent tools for shedding pounds, they are not a permanent solution and long-term success relies on combined behavioural support.
